KAM
CTMX icon

Knightsbridge Asset Management’s CytomX Therapeutics CTMX Stock Holding History

Knightsbridge Asset Management’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-96,926
Closed -$177K – 124
2022
Q2 		$177K Buy
+96,926
New +$177K 0.04% 114